Adamis Pharmaceuticals Corp is a specialty biopharmaceutical company that develops and commercializes products in the therapeutic areas of respiratory disease and allergy. Adamis pharmaceutical product candidates include the Epinephrine Injection PFS syringe product which is used in the emergency treatment of anaphylaxis, APC-1000 and APC-5000 used for treating asthma and chronic obstructive pulmonary disease, and APC-2000 for treatmenting bronchospasms. Through its subsidiary it also provides prescription compounded medications, including compounded sterile preparations, and nonsterile compounds to patients, physician clinics, hospitals, surgery centers and other clients throughout United States. It also provides certain veterinary pharmaceutical products for animals.